---
$id: https://graph.org.ai/products/commodity/51372007
$type: Product
source: UNSPSC
code: "51372007"
title: "Etorphine"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etorphine

**UNSPSC Code**: 51372007
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C25H33NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42M2Y6NU9O, chemically known as 6,7,8,14-tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine but generally known as etorphine, which bears US NIH Compound Identifier 26721. European Medicines Agency schedules Etorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07339MIG. The term ETORPHINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). ETORPHINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etorphine under HS 29391100 and SITC 54141. As of Q4 2014, ETORPHINE remains the US FDA Preferred Term for this commodity. Etorphine bears US NLM identifiers UMLS ID C0015134 and NCI Concept Code C80578. SMILES: O1C2C34C5(C(N(CC3)C)CC3C4C1C(O)CC3)CC(C2(OC)C=C5)C(O)(CCC)C.

